Note: Ingredients listed on restricted chemical lists
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
N/A
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
General Information
Revision date
2020-11-18
Product name
DIMETAPP PSE COUGH COLD & FLU NIGHT RELIEF SOFT CAPSULES
Product Synonyms
DIMETAPP PSEUDOEPHEDRINE COUGH COLD & FLU NIGHT REFLIEF SOFT CAPSULES *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Canada
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 4 Skin corrosion/irritation Category 2 Serious eye damage/eye irritation Category 2 Sensitization, skin Category 1B
Environmental hazards
Not classified.
Signal word
Warning
Hazard statements
Harmful if swallowed. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation.
Prevention
Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Contaminated work clothing should not be allowed out of the workplace. Wear eye protection/face protection. Wear protective gloves.
Response
IF SWALLOWED: Call a POISON CENTRE/doctor/ if you feel unwell. Rinse mouth. IF ON SKIN: Wash with plenty of water/. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Specific treatment (see on this label). If skin irritation or rash occurs Get medical advice/attention. If eye irritation persists Get medical advice/attention. Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
2.3 Other hazards
Occupational Exposure Limits for constituents are listed in Section 8.
Additional information
51.5 % of the mixture consists of component(s) of unknown acute oral toxicity. 80.3 % of the mixture consists of component(s) of unknown acute dermal toxicity. 58 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 58 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
